SCHEMBL4842643

SCHEMBL4842643

CCOC(=O)CCc1ccccc1CN

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.73
CYP4A11 Q02928 3/20 0.73
ALDH1A1 P00352 2/20 0.52
GAA P10253 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.49
MAPT P10636 1/20 0.47
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
LMNA P02545 2/20 0.45
PTPN1 P18031 1/20 0.45
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CDYL Q9Y232 1/20 0.44
EPHX2 P34913 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ALOX5 P09917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4842634 0.98 CYP4F2 (0.71) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL69660 0.91 CYP4F2 (0.86) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
Hydrochloric Acid SCHEMBL11479613 0.89 CYP4F2 (0.67) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL28008696 0.88 CYP4F2 (0.81) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL22098182 0.85 CYP4F2 (1.00) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL22070564 0.85 CYP4F2 (0.76) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL11075331 0.83 CYP4F2 (0.69) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL8852291 0.83 CYP4F2 (0.73) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL11587953 0.83 CYP4F2 (0.73) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2
SCHEMBL28008697 0.83 CYP4F2 (0.73) CYP4F2CYP4A11ALDH1A1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023205458-A2 FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-26 WO disclosed
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 CYP4F2 1271/4885CYP4A11 550/4885ALDH1A1 1819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.